Search
for
Sort by
Research 151–180 of 1000+
- Characteristics and Outcomes of Patients on Tofacitinib for Alopecia Areata or Rheumatoid Arthritis: A Retrospective Cohort Study
- Systemic Lupus Erythematosus: What Every Clinician Needs to Know
- Congenital Adrenal Hyperplasia
- II Consensus of the Brazilian Society of Dermatology for the treatment of alopecia areata
- The Rare Occurrence of a Left Atrial Thrombus in a Dog
- Exploring novel management options for alopecia areata
- Pharmacological Approaches to Controlling Cardiometabolic Risk in Women with PCOS
- Are sex hormones promising candidates to explain sex disparities in the COVID-19 pandemic?
- What’s Sex Got to Do With COVID-19? Gender-Based Differences in the Host Immune Response to Coronaviruses
- Cardiovascular effects of hormone therapy for prostate cancer
- A 70-Year-Old Woman Presenting With Diarrhea and In-hospital Cardiac Arrest
- Carotid Intima Media Thickness Measurement in Alopecia Areata Patients
- Polycystic ovary syndrome: a common reproductive syndrome with long-term metabolic consequences
- Targeting integrin pathways: mechanisms and advances in therapy
- Dermatologic care for lesbian, gay, bisexual, and transgender persons
- Alopecia Areata and Atopic Dermatitis: Common Mechanisms and Emerging Therapeutics
- Cardiovascular Risks in Women with Polycystic Ovary Syndrome (PCOS): A Narrative Review
- Spironolactone: An Anti-androgenic and Anti-hypertensive Drug That May Provide Protection Against the Novel Coronavirus (SARS-CoV-2) Induced Acute Respiratory Distress Syndrome (ARDS) in COVID-19
- Cutaneous manifestations of COVID-19: a systematic review and analysis of individual patient-level data
- Recommendations from the 2023 International Evidence-based Guideline for the Assessment and Management of Polycystic Ovary Syndrome
- Recommendations from the 2023 international evidence-based guideline for the assessment and management of polycystic ovary syndrome
- Long‐term efficacy and safety of baricitinib in patients with severe alopecia areata: 104‐week results from BRAVE‐AA1 and BRAVE‐AA2
- Presentation and Management of Cutaneous Manifestations of COVID-19
- Polycystic Ovary Syndrome: Explaining the Gynecological Aspects and Treatment Options to Patients
- Polycystic ovary syndrome
- Is COVID-19 a risk factor for progression of benign prostatic hyperplasia and exacerbation of its related symptoms?: a systematic review
- Post severe COVID-19 infection lung damages study. The experience of early three months multidisciplinary follow-up
- Research progress of post-acute sequelae after SARS-CoV-2 infection
- Identification of hepatic molecular mechanisms of action of alpha-tocopherol using global gene expression profile analysis in rats
- WARFARIN-INDUCED ALOPECIA: A RARE CASE REPORT